Genotyping Market Report: Trends, Forecast and Competitive Analysis
Get it in 2 to 4 weeks by ordering today
The future of the genotyping market looks promising with opportunities in diagnostics, drug discovery personalized medicine, academic research, and agriculture applications. The global genotyping market is expected to grow with a CAGR of 20%-25% from 2020 to 2025. The major drivers for this market are increasing research and development activities in the healthcare sector, rising prevalence of genetic diseases, and technological advancement in gene studies.
A total of XX figures / charts and XX tables are provided in this more than 150-pages report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global genotyping market report, please download the report brochure.
In this market, reagents & kits is the largest product of genotyping, whereas personalized medicine is the largest application. Growth in various segments of the genotyping market are given below:
The study includes trends and forecast for the global genotyping market by product, technology, application, end user, and region as follows:
By Product [Value ($ Million) shipment analysis for 2014 – 2025]:
Reagents and KitsInstrumentsServices
By Technology [Value ($ Million) shipment analysis for 2014 – 2025]:
PCR (Polymerase Chain Reaction)Capillary ElectrophoresisMass SpectrometrySequencingMicroarrayOthers
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
DiagnosticsDrug Discovery and DevelopmentPersonalized MedicineAcademic ResearchAgricultural Biotechnology and Others
By End User [Value ($ Million) shipment analysis for 2014 – 2025]:
Pharmaceutical & Biopharmaceutical Companies Diagnostic & Research Laboratories Academic Institutes Other End Users
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
North AmericaUnited StatesCanada MexicoEuropeUnited KingdomSpainGermanyFranceAsia PacificChinaIndiaJapanThe Rest of the WorldBrazil
Some of the genotyping model companies profiled in this report includes QIAGEN, Affymetrix, Illumina, Thermo Fisher Scientific, General Electric, Agilent Technologies, and Roche.
Lucintel forecasts that reagents and kits will remain the largest product segment over the forecast period due to a wide usage rate, surging demand for genotyping tests, cost-effectiveness, and easy availability of reagents.
Within this market, personalized medicine will remain the largest application segment over the forecast period due to rising government support for personalized medicine, changing reimbursement and regulatory landscape, and the growing adoption of sequencing for genetic mapping.
North America will remain the largest region over the forecast period due to the well-established healthcare infrastructure and rapid advancements in technology in the region.
Features of the Global Genotyping Market
Market Size Estimates: Global genotyping market size estimation in terms of value ($M) shipment.Trend and Forecast Analysis: Market trends (2014-2019) and forecast (2020-2025) by various segments.Segmentation Analysis: Global genotyping market size by various segments, such as product, technology, application, and end user in terms of value.Regional Analysis: Global genotyping market breakdown by North America, Europe, Asia Pacific, and Rest of the World.Growth Opportunities: Analysis of growth opportunities in different product, technology, application, end user, and region for the global genotyping market.Strategic Analysis: This includes M&A, new product development, and competitive landscape of the global genotyping market.Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
This report answers following key questions
Q.1 What are some of the most promising potential, high-growth opportunities for the global genotyping market by product (reagents and kits, instruments, and services), technology (PCR (polymerase chain reaction), capillary electrophoresis, mass spectrometry, sequencing, microarray, and others), application (diagnostics, drug discovery and development, personalized medicine, academic research, and agricultural biotechnology & others), end user (pharmaceutical & biopharmaceutical companies, diagnostic & research laboratories, academic institutes, and other end users), and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global genotyping market?
Q.5 What are the business risks and threats to the global genotyping market?
Q.6 What are the emerging trends in this genotyping market and the reasons behind them?
Q.7 What are some changing demands of customers in this genotyping market?
Q.8 What are the new developments in this genotyping market? Which companies are leading these developments?
Q.9 Who are the major players in this genotyping market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this genotyping market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global genotyping market?
Report Scope
Key Features Description
Base Year for Estimation 2019
Trend Period
(Actual Estimates) 2014-2019
Forecast Period 2020-2025
Pages More than 150
Market Representation / Units Revenue in US $ Million
Report Coverage Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling
Market Segments Product (Reagents and Kits, Instruments, and Services), Technology (PCR (Polymerase Chain Reaction), Capillary Electrophoresis, Mass Spectrometry, Sequencing, Microarray, and Others), Application (Diagnostics, Drug Discovery and Development, Personalized Medicine, Academic Research, and Agricultural Biotechnology & Others), and End User (Pharmaceutical & Biopharmaceutical Companies, Diagnostic & Research Laboratories, Academic Institutes, and Other End Users)
Regional Scope North America (USA, Mexico, and Canada), Europe (United Kingdom, Spain, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil)
Customization 10% Customization without Any Additional Cost
The future of the genotyping market looks promising with opportunities in diagnostics, drug discovery personalized medicine, academic research, and agriculture applications. The global genotyping market is expected to grow with a CAGR of 20%-25% from 2020 to 2025. The major drivers for this market are increasing research and development activities in the healthcare sector, rising prevalence of genetic diseases, and technological advancement in gene studies.
A total of XX figures / charts and XX tables are provided in this more than 150-pages report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global genotyping market report, please download the report brochure.
In this market, reagents & kits is the largest product of genotyping, whereas personalized medicine is the largest application. Growth in various segments of the genotyping market are given below:
The study includes trends and forecast for the global genotyping market by product, technology, application, end user, and region as follows:
By Product [Value ($ Million) shipment analysis for 2014 – 2025]:
Reagents and KitsInstrumentsServices
By Technology [Value ($ Million) shipment analysis for 2014 – 2025]:
PCR (Polymerase Chain Reaction)Capillary ElectrophoresisMass SpectrometrySequencingMicroarrayOthers
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
DiagnosticsDrug Discovery and DevelopmentPersonalized MedicineAcademic ResearchAgricultural Biotechnology and Others
By End User [Value ($ Million) shipment analysis for 2014 – 2025]:
Pharmaceutical & Biopharmaceutical Companies Diagnostic & Research Laboratories Academic Institutes Other End Users
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
North AmericaUnited StatesCanada MexicoEuropeUnited KingdomSpainGermanyFranceAsia PacificChinaIndiaJapanThe Rest of the WorldBrazil
Some of the genotyping model companies profiled in this report includes QIAGEN, Affymetrix, Illumina, Thermo Fisher Scientific, General Electric, Agilent Technologies, and Roche.
Lucintel forecasts that reagents and kits will remain the largest product segment over the forecast period due to a wide usage rate, surging demand for genotyping tests, cost-effectiveness, and easy availability of reagents.
Within this market, personalized medicine will remain the largest application segment over the forecast period due to rising government support for personalized medicine, changing reimbursement and regulatory landscape, and the growing adoption of sequencing for genetic mapping.
North America will remain the largest region over the forecast period due to the well-established healthcare infrastructure and rapid advancements in technology in the region.
Features of the Global Genotyping Market
Market Size Estimates: Global genotyping market size estimation in terms of value ($M) shipment.Trend and Forecast Analysis: Market trends (2014-2019) and forecast (2020-2025) by various segments.Segmentation Analysis: Global genotyping market size by various segments, such as product, technology, application, and end user in terms of value.Regional Analysis: Global genotyping market breakdown by North America, Europe, Asia Pacific, and Rest of the World.Growth Opportunities: Analysis of growth opportunities in different product, technology, application, end user, and region for the global genotyping market.Strategic Analysis: This includes M&A, new product development, and competitive landscape of the global genotyping market.Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
This report answers following key questions
Q.1 What are some of the most promising potential, high-growth opportunities for the global genotyping market by product (reagents and kits, instruments, and services), technology (PCR (polymerase chain reaction), capillary electrophoresis, mass spectrometry, sequencing, microarray, and others), application (diagnostics, drug discovery and development, personalized medicine, academic research, and agricultural biotechnology & others), end user (pharmaceutical & biopharmaceutical companies, diagnostic & research laboratories, academic institutes, and other end users), and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global genotyping market?
Q.5 What are the business risks and threats to the global genotyping market?
Q.6 What are the emerging trends in this genotyping market and the reasons behind them?
Q.7 What are some changing demands of customers in this genotyping market?
Q.8 What are the new developments in this genotyping market? Which companies are leading these developments?
Q.9 Who are the major players in this genotyping market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this genotyping market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global genotyping market?
Report Scope
Key Features Description
Base Year for Estimation 2019
Trend Period
(Actual Estimates) 2014-2019
Forecast Period 2020-2025
Pages More than 150
Market Representation / Units Revenue in US $ Million
Report Coverage Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling
Market Segments Product (Reagents and Kits, Instruments, and Services), Technology (PCR (Polymerase Chain Reaction), Capillary Electrophoresis, Mass Spectrometry, Sequencing, Microarray, and Others), Application (Diagnostics, Drug Discovery and Development, Personalized Medicine, Academic Research, and Agricultural Biotechnology & Others), and End User (Pharmaceutical & Biopharmaceutical Companies, Diagnostic & Research Laboratories, Academic Institutes, and Other End Users)
Regional Scope North America (USA, Mexico, and Canada), Europe (United Kingdom, Spain, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil)
Customization 10% Customization without Any Additional Cost
1. EXECUTIVE SUMMARY
2. MARKET BACKGROUND AND CLASSIFICATIONS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2014 T 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Genotyping Market Trends and Forecast
3.3: Global Genotyping Market by Product
3.3.1: Reagents and Kits
3.3.2: Instruments
3.3.3: Services
3.4: Global Genotyping Market by Technology
3.4.1: PCR (Polymerase Chain Reaction)
3.4.2: Capillary Electrophoresis
3.4.3: Mass Spectrometry
3.4.4: Sequencing
3.4.5: Microarray
3.4.6: Others
3.5: Global Genotyping Market by Application
3.5.1: Diagnostics
3.5.2: Drug Discovery and Development
3.5.3: Personalized Medicine
3.5.4: Academic Research
3.5.5: Agricultural Biotechnology and Others
3.6: Global Genotyping Market by End User
3.6.1: Pharmaceutical & Biopharmaceutical Companies
3.6.2: Diagnostic & Research Laboratories
3.6.3: Academic Institutes
3.6.4: Other End Users
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION
4.1: Global Genotyping Market by Region
4.2: North American Genotyping Market
4.2.1: Market by Product: Reagents and Kits, Instruments, and Services
4.2.2: Market by Technology: PCR (Polymerase Chain Reaction), Capillary Electrophoresis, Mass Spectrometry, Sequencing, Microarray, and Others
4.2.3: Market by Application: Diagnostics, Drug Discovery and Development, Personalized Medicine, Academic Research, and Agricultural Biotechnology & Others
4.2.4: Market by End User: Pharmaceutical & Biopharmaceutical Companies, Diagnostic & Research Laboratories, Academic Institutes, and Other End Users
4.2.5: The United States Genotyping Market
4.2.6: The Canadian Genotyping Market
4.2.7: The Mexican Genotyping Market
4.3: European Genotyping Market
4.3.1: Market by Product: Reagents and Kits, Instruments, and Services
4.3.2: Market by Technology: PCR (Polymerase Chain Reaction), Capillary Electrophoresis, Mass Spectrometry, Sequencing, Microarray, and Others
4.3.3: Market by Application: Diagnostics, Drug Discovery and Development, Personalized Medicine, Academic Research, and Agricultural Biotechnology & Others
4.3.4: Market by End User: Pharmaceutical & Biopharmaceutical Companies, Diagnostic & Research Laboratories, Academic Institutes, and Other End Users
4.3.5: The United Kingdom Genotyping Market
4.3.6: The Spanish Genotyping Market
4.3.7: The German Genotyping Market
4.3.8: The French Genotyping Market
4.4: APAC Genotyping Market
4.4.1: Market by Product: Reagents and Kits, Instruments, and Services
4.4.2: Market by Technology: PCR (Polymerase Chain Reaction), Capillary Electrophoresis, Mass Spectrometry, Sequencing, Microarray, and Others
4.4.3: Market by Application: Diagnostics, Drug Discovery and Development, Personalized Medicine, Academic Research, and Agricultural Biotechnology & Others
4.4.4: Market by End User: Pharmaceutical & Biopharmaceutical Companies, Diagnostic & Research Laboratories, Academic Institutes, and Other End Users
4.4.5: The Chinese Genotyping Market
4.4.6: The Indian Genotyping Market
4.4.7: The Japanese Genotyping Market
4.5: ROW Genotyping Market
4.5.1: Market by Product: Reagents and Kits, Instruments, and Services
4.5.2: Market by Technology: PCR (Polymerase Chain Reaction), Capillary Electrophoresis, Mass Spectrometry, Sequencing, Microarray, and Others
4.5.3: Market by Application: Diagnostics, Drug Discovery and Development, Personalized Medicine, Academic Research, and Agricultural Biotechnology & Others
4.5.4: Market by End User: Pharmaceutical & Biopharmaceutical Companies, Diagnostic & Research Laboratories, Academic Institutes, and Other End Users
4.5.5: Brazilian Genotyping Market
5. COMPETITOR ANALYSIS
5.1: Market Share Analysis
5.2: Product Portfoli Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. COST STRUCTURE ANALYSIS
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Genotyping Market by Product
7.1.2: Growth Opportunities for the Global Genotyping Market by Technology
7.1.3: Growth Opportunities for the Global Genotyping Market by Application
7.1.4: Growth Opportunities for the Global Genotyping Market by End User
7.1.5: Growth Opportunities for the Global Genotyping Market by Region
7.2: Emerging Trends in the Global Genotyping Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global Genotyping Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Genotyping Market
7.3.4: Certification and Licensing
8. COMPANY PROFILES OF LEADING PLAYERS
8.1: QIAGEN
8.2: Affymetrix, Inc.
8.3: Illumina, Inc
8.4: Therm Fisher Scientific, Inc.
8.5: GE Healthcare
8.6: Agilent Technologies, Inc.
8.7: F. Hoffmann-La Roche Ltd
8.8: Company
8.9: Company
8.10: Company
2. MARKET BACKGROUND AND CLASSIFICATIONS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2014 T 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Genotyping Market Trends and Forecast
3.3: Global Genotyping Market by Product
3.3.1: Reagents and Kits
3.3.2: Instruments
3.3.3: Services
3.4: Global Genotyping Market by Technology
3.4.1: PCR (Polymerase Chain Reaction)
3.4.2: Capillary Electrophoresis
3.4.3: Mass Spectrometry
3.4.4: Sequencing
3.4.5: Microarray
3.4.6: Others
3.5: Global Genotyping Market by Application
3.5.1: Diagnostics
3.5.2: Drug Discovery and Development
3.5.3: Personalized Medicine
3.5.4: Academic Research
3.5.5: Agricultural Biotechnology and Others
3.6: Global Genotyping Market by End User
3.6.1: Pharmaceutical & Biopharmaceutical Companies
3.6.2: Diagnostic & Research Laboratories
3.6.3: Academic Institutes
3.6.4: Other End Users
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION
4.1: Global Genotyping Market by Region
4.2: North American Genotyping Market
4.2.1: Market by Product: Reagents and Kits, Instruments, and Services
4.2.2: Market by Technology: PCR (Polymerase Chain Reaction), Capillary Electrophoresis, Mass Spectrometry, Sequencing, Microarray, and Others
4.2.3: Market by Application: Diagnostics, Drug Discovery and Development, Personalized Medicine, Academic Research, and Agricultural Biotechnology & Others
4.2.4: Market by End User: Pharmaceutical & Biopharmaceutical Companies, Diagnostic & Research Laboratories, Academic Institutes, and Other End Users
4.2.5: The United States Genotyping Market
4.2.6: The Canadian Genotyping Market
4.2.7: The Mexican Genotyping Market
4.3: European Genotyping Market
4.3.1: Market by Product: Reagents and Kits, Instruments, and Services
4.3.2: Market by Technology: PCR (Polymerase Chain Reaction), Capillary Electrophoresis, Mass Spectrometry, Sequencing, Microarray, and Others
4.3.3: Market by Application: Diagnostics, Drug Discovery and Development, Personalized Medicine, Academic Research, and Agricultural Biotechnology & Others
4.3.4: Market by End User: Pharmaceutical & Biopharmaceutical Companies, Diagnostic & Research Laboratories, Academic Institutes, and Other End Users
4.3.5: The United Kingdom Genotyping Market
4.3.6: The Spanish Genotyping Market
4.3.7: The German Genotyping Market
4.3.8: The French Genotyping Market
4.4: APAC Genotyping Market
4.4.1: Market by Product: Reagents and Kits, Instruments, and Services
4.4.2: Market by Technology: PCR (Polymerase Chain Reaction), Capillary Electrophoresis, Mass Spectrometry, Sequencing, Microarray, and Others
4.4.3: Market by Application: Diagnostics, Drug Discovery and Development, Personalized Medicine, Academic Research, and Agricultural Biotechnology & Others
4.4.4: Market by End User: Pharmaceutical & Biopharmaceutical Companies, Diagnostic & Research Laboratories, Academic Institutes, and Other End Users
4.4.5: The Chinese Genotyping Market
4.4.6: The Indian Genotyping Market
4.4.7: The Japanese Genotyping Market
4.5: ROW Genotyping Market
4.5.1: Market by Product: Reagents and Kits, Instruments, and Services
4.5.2: Market by Technology: PCR (Polymerase Chain Reaction), Capillary Electrophoresis, Mass Spectrometry, Sequencing, Microarray, and Others
4.5.3: Market by Application: Diagnostics, Drug Discovery and Development, Personalized Medicine, Academic Research, and Agricultural Biotechnology & Others
4.5.4: Market by End User: Pharmaceutical & Biopharmaceutical Companies, Diagnostic & Research Laboratories, Academic Institutes, and Other End Users
4.5.5: Brazilian Genotyping Market
5. COMPETITOR ANALYSIS
5.1: Market Share Analysis
5.2: Product Portfoli Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. COST STRUCTURE ANALYSIS
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Genotyping Market by Product
7.1.2: Growth Opportunities for the Global Genotyping Market by Technology
7.1.3: Growth Opportunities for the Global Genotyping Market by Application
7.1.4: Growth Opportunities for the Global Genotyping Market by End User
7.1.5: Growth Opportunities for the Global Genotyping Market by Region
7.2: Emerging Trends in the Global Genotyping Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global Genotyping Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Genotyping Market
7.3.4: Certification and Licensing
8. COMPANY PROFILES OF LEADING PLAYERS
8.1: QIAGEN
8.2: Affymetrix, Inc.
8.3: Illumina, Inc
8.4: Therm Fisher Scientific, Inc.
8.5: GE Healthcare
8.6: Agilent Technologies, Inc.
8.7: F. Hoffmann-La Roche Ltd
8.8: Company
8.9: Company
8.10: Company
